Palisade Bio (PALI)
NASDAQ:PALI
Holding PALI?
Track your performance easily

Palisade Bio (PALI) Income Statement

474 Followers

Palisade Bio Income Statement

Last quarter (Q2 2024), Palisade Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Palisade Bio's net income was $-4.08M. See Palisade Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
-$ 250.00K--$ 13.52K
Cost of Revenue
-----
Gross Profit
-$ 250.00K--$ 13.52K
Operating Expense
$ 14.59M$ 13.10M$ 15.31M$ 41.85M$ 9.30M
Operating Income
$ -14.82M$ -13.07M$ -15.72M$ -41.85M$ -9.30M
Net Non Operating Interest Income Expense
$ -15.00K$ -15.00K$ -13.00K$ -2.40M$ -235.00K
Other Income Expense
$ 688.00K$ 560.00K$ 1.06M$ -17.64M$ 790.00K
Pretax Income
$ -14.17M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Tax Provision
$ -810.00K$ -810.00K$ -1.04M$ -1.31M$ -2.09M
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -14.19M$ -12.32M$ -14.55M$ -26.62M$ -10.32M
Basic EPS
$ -8.64$ -1.80$ -247.95$ -2.15K$ -5.26K
Diluted EPS
$ -8.64$ -1.80$ -247.95$ -2.54K$ -5.26K
Basic Average Shares
$ 18.62M$ 6.84M$ 58.69K$ 12.41K$ 3.08K
Diluted Average Shares
$ 18.62M$ 6.84M$ 58.69K$ 12.46K-
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 14.82M$ 13.10M$ 15.31M$ 41.85M$ 9.30M
Net Income From Continuing And Discontinued Operation
$ -14.17M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Normalized Income
$ -14.08M$ -12.88M-$ -27.93M-
Interest Expense
-----
EBIT
$ -14.16M$ -12.29M$ -14.25M$ -24.22M$ -10.09M
EBITDA
$ -14.16M$ -12.28M$ -14.24M$ -24.22M$ -10.08M
Currency in USD

Palisade Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis